Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 48Neoplasms 43Depression 31Fatigue 30Prostatic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, Follicular 18Lymphoma, Large B-Cell, Diffuse 17Multiple Myeloma 16Carcinoma, Non-Small-Cell Lung 16Lymphoma, Non-Hodgkin 15Lung Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Mantle-Cell 14Leukemia, Myeloid, Acute 14Hodgkin Disease 14Colorectal Neoplasms 14Burkitt Lymphoma 14Anxiety Disorders 14Pain 13Lymphoma, B-Cell, Marginal Zone 13Lymphoma, Large-Cell, Immunoblastic 12Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Head and Neck Neoplasms 11Blast Crisis 11Lymphoma, T-Cell, Cutaneous 10Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Hairy Cell 10

Interventions

Bupivacaine 11Ketamine 9Ropivacaine 8Morphine 8Analgesics, Opioid 8Acetaminophen 8Fentanyl 7Dexmedetomidine 7Lidocaine 6Anesthesia, General 6Saline Solution 5Anesthesia, Local 5Acupuncture Therapy 5parecoxib 4Tramadol 4Surveys and Questionnaires 4Sodium Chloride 4Pregabalin 4Ethanol 4Analgesia, Epidural 4Transcutaneous Electric Nerve Stimulation 3Radiofrequency Ablation 3Propofol 3Oxycodone 3Ketorolac 3Control Groups 3Anesthetics, Local 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Therapeutics 2Tea 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Agnosia × Therapeutics × Clear all
NCT06947577 2025-08-20

PEMFTEPCHIN

Cairo University

Phase 4 Completed
80 enrolled

Agnosia

NCT03661840 2025-03-13

Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

University of Colorado, Denver

Phase NA Completed
50 enrolled 12 charts

Agnosia, Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡